Last year, Washington Research Foundation (WRF) and Fred Hutchinson Cancer Center (Fred Hutch) launched a new collaborative funding program to advance technologies that can have a significant impact on improving the health of communities. Since then, WRF has awarded two cycles of $750,000 in funding that have supported 11 technology commercialization projects at Fred Hutch with grants between $50,000 and $250,000. Today, WRF announces an additional $1 million to Fred Hutch to continue support for the program.
“This program is enabling researchers at Fred Hutch to take their discoveries one step closer to becoming therapeutic products and interventions that could potentially transform how diseases are treated,” said Hilary Hehman, M.S., J.D., vice president, Business Development, Fred Hutch. “The additional funding from WRF allows us to continue operating the program and supporting researchers who are on the frontlines of innovative science.”
